XML 11 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating activities:    
Net income (loss) $ 69,682 $ (1,758,560)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 437,816 601,194
Stock-based compensation 15,918 22,604
Non-cash life insurance policy reduction / (accretion) 20,329
Non-cash other revenue (259,299)
Non-cash miscellaneous loss 24,618
(Gain) loss on sale of property, plant and equipment (434,549) 3,966
Foreign currency transaction (gain) loss 18,942 8,983
(Increase) decrease in trade, accounts & notes receivable, and deposits from related parties (812,477) (295,226)
(Increase) decrease in inventories 1,090,895 31,270
(Increase) decrease in refundable income taxes (2,251) 3,373
(Increase) decrease in prepaid expenses and other current assets (45,501) (212,124)
(Increase) decrease in other assets (76,128) (63,302)
Increase (decrease) in income taxes payable 11,323 (5,711)
Increase (decrease) in accounts payable & accrued expenses, deferred revenue, and other noncurrent liabilities (12,350) 793,335
Net cash provided by (used in) operating activities 26,639 (849,869)
Investing activities:    
Purchase of property, plant and equipment (84,457) (96,700)
Proceeds from the sale of property, plant and equipment 5,270
Proceeds from the redemption of life insurance policy 3,066,193
Payments received on notes receivables - related parties 131,003 86,266
Net cash provided by investing activities 46,546 3,061,029
Financing activities:    
Proceeds from line of credit borrowings 500,000
Principal payments on long-term borrowings (3,045,421)
Net cash provided by (used in) financing activities 500,000 (3,045,421)
Effect of exchange rate changes on cash and cash equivalents (22,380) (65,690)
Increase (decrease) in cash and cash equivalents 550,805 (899,951)
Cash and cash equivalents at beginning of period 1,989,974 3,272,788
Cash and cash equivalents at end of period $ 2,540,779 $ 2,372,837